We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.8B
AUM Growth
+$1.26B
Cap. Flow
+$567M
Cap. Flow %
3.2%
Top 10 Hldgs %
11.28%
Holding
2,904
New
221
Increased
694
Reduced
820
Closed
148

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$82.7M
2
PEP icon
PepsiCo
PEP
+$76.8M
3
MAR icon
Marriott International
MAR
+$64.8M
4
TSN icon
Tyson Foods
TSN
+$62.8M
5
PARA
Paramount Global Class B
PARA
+$52.9M

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$64.8M
2
HRL icon
Hormel Foods
HRL
+$61.4M
3
GILD icon
Gilead Sciences
GILD
+$59.9M
4
HLT icon
Hilton Worldwide
HLT
+$54.7M
5
FTI icon
TechnipFMC
FTI
+$51M

Sector Composition

Rank Sector Weight
1 Technology 14.87%
2 Healthcare 14.18%
3 Financials 11.71%
4 Industrials 10.79%
5 Consumer Discretionary 10.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OMN
2301
DELISTED
OMNOVA Solutions Inc.
OMN
$0 ﹤0.01%
+111
New +$1.03K
DERM
2302
DELISTED
Dermira, Inc.
DERM
– –
-5,827
Closed -$170K
CARB
2303
DELISTED
Carbonite Inc
CARB
– –
-11,257
Closed -$109K
ALL.PRE.CL
2304
DELISTED
Allstate Corporation Depositary Shares
ALL.PRE.CL
– –
-300
Closed -$8K
TYPE
2305
DELISTED
Monotype Imaging Holdings Inc.
TYPE
– –
-5,249
Closed -$129K
NRE
2306
DELISTED
NorthStar Realty Europe Corp.
NRE
– –
-37
Closed –
ARRY
2307
DELISTED
Array Biopharma Inc
ARRY
– –
-900
Closed -$3K
PETX
2308
DELISTED
Aratana Therapeutics, Inc.
PETX
$0 ﹤0.01%
+106
New +$880
GM.WS.B
2309
DELISTED
General Motors Company
GM.WS.B
$0 ﹤0.01%
5
– –
ESL
2310
DELISTED
Esterline Technologies
ESL
– –
-81
Closed -$5K
NXTM
2311
DELISTED
NxStage Medical Inc.
NXTM
$0 ﹤0.01%
1
– –
LOXO
2312
DELISTED
Loxo Oncology, Inc
LOXO
– –
-115
Closed -$2K
CYHHZ
2313
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$0 ﹤0.01%
1,002
– –
FBR
2314
DELISTED
Fibria Celulose Sa
FBR
$0 ﹤0.01%
139
– –
XOXO
2315
DELISTED
Xo Group Inc
XOXO
– –
-86
Closed -$1K
EEQ
2316
DELISTED
Enbridge Energy Management Llc
EEQ
– –
-66,432
Closed -$1.21M
OCLR
2317
DELISTED
Oclaro Inc.
OCLR
– –
-302
Closed -$1K
PNK
2318
DELISTED
Pinnacle Entertainment Inc.
PNK
$0 ﹤0.01%
2
– –
FNGN
2319
DELISTED
Financial Engines, Inc.
FNGN
– –
-100
Closed -$2K
VR
2320
DELISTED
Validus Hold Ltd
VR
– –
-21
Closed -$1K
JASO
2321
DELISTED
JA Solar Holdings, Co., Ltd
JASO
$0 ﹤0.01%
95
– –
WGL
2322
DELISTED
Wgl Holdings
WGL
$0 ﹤0.01%
24
– –
YGE
2323
DELISTED
Yingli Green Energy Holding Comp
YGE
$0 ﹤0.01%
57
– –
IPXL
2324
DELISTED
Impax Laboratories, Inc.
IPXL
$0 ﹤0.01%
39
– –
CALD
2325
DELISTED
Callidus Software, Inc.
CALD
$0 ﹤0.01%
+48
New +$938
91 92
93
94 95

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q3 2016 Portfolio in Review

As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.

  • Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
  • Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
  • Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
  • Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
  • Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
  • Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
  • Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.

Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.